Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001921134 | SCV002189296 | uncertain significance | Senior-Loken syndrome 7; Bardet-Biedl syndrome 16 | 2021-09-15 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. This variant has not been reported in the literature in individuals affected with SDCCAG8-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces leucine with serine at codon 250 of the SDCCAG8 protein (p.Leu250Ser). The leucine residue is highly conserved and there is a large physicochemical difference between leucine and serine. |
Fulgent Genetics, |
RCV001921134 | SCV002787762 | uncertain significance | Senior-Loken syndrome 7; Bardet-Biedl syndrome 16 | 2021-12-15 | criteria provided, single submitter | clinical testing |